As the COVID-19 pandemic shuts down the world’s economies, stock markets plummet and unemployment rises, policymakers will be forced to figure out how to contain the outbreak while preventing financial and economic collapse. Most economic proposals in developed countries focus on cash payments to people, deferred tax payments and business bailouts.
However, biomedicine is critical to saving the economy, and of the three major biomedical channels now in play, the least important medically is the one that could impede an economic Armageddon.
It is a test to check whether a person has had, recovered from and thus become immune to COVID-19. Scientists say that low-symptom and symptomless cases exceed the symptomatic. When these asymptomatic people are over the infection, they could go to work — they will not infect those with whom they come into contact. But we need to know who they are.
Imagine that we could test the low-symptom and no-symptom cases for immunity today. This is not the widely discussed (and still not widely available) test for the illness itself. That test shows whether the virus is in one’s system, not whether it came, went and conferred immunity. Testing those who have been exposed, recovered and are healthy could allow them to return to work and reopen businesses and institutions.
Initial public discussion of immunity testing — which is sparse — has focused on how understanding COVID-19 immunity could lead to a vaccine or antiviral to treat the sick, and could tell us how widely the virus has spread.
However, a major and immediate economic use of an immunity test is that it can be deployed before we have a cure or a treatment. Initial research suggests that, as with other viral diseases, recovery from COVID-19 does indeed lead to post-illness immunity. This still needs to be fully confirmed — and, equally important, confirmed to be long-lasting. Such testing is now possible and, with a push, could be widely available.
That push could be well worth the effort, especially if the virus spreads. The public health focus is on developing therapeutic drugs and a vaccine as soon as possible.
However, no widely available vaccine is expected to be available for 12 to 18 months — far longer than the world’s economies can stay shut down.
Likewise, antivirals to treat the disease will save lives and must be a priority, but the strength of their impact on the economy is uncertain. People will still get sick. Moreover, effective antivirals are expected to come in months, maybe many months, not weeks. The economy cannot wait that long.
Consider how an immunity test could be used today. My wife and I had a cold for a day last week: a light, dry cough and a little congestion. Was it a mild form of COVID-19, which our immune systems fought off without serious symptoms? Probably not, but maybe it was — and maybe we are now immune. If an immunity test were available, we would check, and if we were immune, we would go out and back to the office. However, because we do not know, we are still staying home.
I am not an epidemiologist, although an epidemiologist at my university has raised similar possibilities. Much about COVID-19 is uncertain in public discourse and, so it seems, in experts’ knowledge. For example, the economic value of the immunity test depends on how many people get the virus without being symptomatic and on the overall level of infection in the coming months, neither of which we know now with any precision.
An immunity test would have to be easy to use, because it is the asymptomatic who would have to use it. Presumably, some of the first users would be businesses that would have to close unless they could be staffed with a handful of immune employees.
Perversely, the worse the public-health situation is, the higher the economic value of the immunity test. If more people are infected, the economy is more disrupted, and the number of symptomless patients who need not stay home rises as well.
That might be a path to a low-casualty means of minimizing the pandemic’s economic: those who have recovered resume their normal routine. The numbers will increase sharply, according to some projections. The problem is finding out who they are.
An immunity test could tell us who does not need to be taken out of economic circulation, and using it well could start our economic recovery as early as next month — or impede a further decline. And if the uncertainties are overcome, it could proceed while the more complete biomedical efforts — to develop antivirals and a vaccine — percolate toward a solution in laboratories around the world.
Mark Roe is a professor at Harvard Law School. He is the author of studies of the impact of politics on corporate organization and corporate governance in the US and around the world.
Copyright: Project Syndicate
In an article published in Newsweek on Monday last week, President William Lai (賴清德) challenged China to retake territories it lost to Russia in the 19th century rather than invade Taiwan. “If it is really for the sake of territorial integrity, why doesn’t China take back Russia?” Lai asked, referring to territories lost in 1858 and 1860. The territories once made up the two flanks of northern Manchuria. Once ceded to Russia, they became part of the Russian far east. Claims since then have been made that China and Russia settled the disputes in the 1990s through the 2000s and that “China
China has successfully held its Forum on China-Africa Cooperation, with 53 of 55 countries from the African Union (AU) participating. The two countries that did not participate were Eswatini and the Sahrawi Arab Democratic Republic, which have no diplomatic relations with China. Twenty-four leaders were reported to have participated. Despite African countries complaining about summit fatigue, with recent summits held with Russia, Italy, South Korea, the US and Indonesia, as well as Japan next month, they still turned up in large numbers in Beijing. China’s ability to attract most of the African leaders to a summit demonstrates that it is still being
Trips to the Kenting Peninsula in Pingtung County have dredged up a lot of public debate and furor, with many complaints about how expensive and unreasonable lodging is. Some people even call it a tourist “butchering ground.” Many local business owners stake claims to beach areas by setting up parasols and driving away people who do not rent them. The managing authority for the area — Kenting National Park — has long ignored the issue. Ultimately, this has affected the willingness of domestic travelers to go there, causing tourist numbers to plummet. In 2008, Taiwan opened the door to Chinese tourists and in
Taiwan People’s Party (TPP) Chairman Ko Wen-je (柯文哲) on Thursday was handcuffed and escorted by police to the Taipei Detention Center, after the Taipei District Court ordered that he be detained and held incommunicado for suspected corruption during his tenure as Taipei mayor. The ruling reversed an earlier decision by the same court on Monday last week that ordered Ko’s release without bail. That decision was appealed by prosecutors on Wednesday, leading the High Court to conclude that Ko had been “actively involved” in the alleged corruption and it ordered the district court to hold a second detention hearing. Video clips
RSS